Generated on March 12 2026 16:59 PM
Old data? UPDATE !
The score is 57/100
Title
Ultragenyx—Treatment of Rare and Ultrarare Genetic Diseases
Length : 59
Perfect, your title contains between 10 and 70 characters.
Description
Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Length : 145
Great, your meta description contains between 70 and 160 characters.
Keywords
Very bad. We haven't found meta keywords on your page. Use this free online meta tags generator to create keywords.
Og Meta Properties
Good, your page take advantage of Og Properties.
| Property | Content |
|---|---|
| locale | en_US |
| type | website |
| title | Ultragenyx—Treatment of Rare and Ultrarare Genetic Diseases |
| description | Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward. |
| url | https://www.ultragenyx.com/ |
| site_name | Ultragenyx |
| image | https://www.ultragenyx.com/wp-content/uploads/2023/02/ultragenyx-logo.png |
| image:width | 1000 |
| image:height | 374 |
| image:type | image/png |
Headings
| H1 | H2 | H3 | H4 | H5 | H6 |
| 1 | 11 | 0 | 0 | 0 | 0 |
Images
We found 54 images on this web page.
Good, most or all of your images have alt attributes.
Text/HTML Ratio
Ratio : 1%
This page's ratio of text to HTML code is below 15 percent, this means that your website probably needs more text content.
Flash
Perfect, no Flash content has been detected on this page.
Iframe
Too Bad, you have Iframes on the web pages, this mean that content in an Iframe cannot be indexed.
URL Rewrite
Good. Your links looks friendly!
Underscores in the URLs
Perfect! No underscores detected in your URLs.
In-page links
We found a total of 48 links including 0 link(s) to files
| Anchor | Type | Juice |
|---|---|---|
| Patient Advocacy | External | Passing Juice |
| Home | Internal | Passing Juice |
| Learn more | Internal | Passing Juice |
| Leadership | Internal | Passing Juice |
| Access to Our Therapies | Internal | Passing Juice |
| Early Access | Internal | Passing Juice |
| Access Resources | Internal | Passing Juice |
| Corporate Responsibility | Internal | Passing Juice |
| Grants & Contributions | Internal | Passing Juice |
| Patient Advocacy | External | Passing Juice |
| Learn more | Internal | Passing Juice |
| Our Science | Internal | Passing Juice |
| Our Gene Therapy Platform | Internal | Passing Juice |
| DTX401 for GSDIa | Internal | Passing Juice |
| DTX301 for OTC Deficiency | Internal | Passing Juice |
| UX701 for Wilson Disease | Internal | Passing Juice |
| UX143 for OI | Internal | Passing Juice |
| GTX-102 for AS | Internal | Passing Juice |
| UX111 for MPS IIIA | Internal | Passing Juice |
| UX055 for CDD | Internal | Passing Juice |
| Our Clinical Trial Transparency Commitment | Internal | Passing Juice |
| Disease Monitoring Programs | Internal | Passing Juice |
| Medicines | Internal | Passing Juice |
| Partnerships | Internal | Passing Juice |
| Learn more | Internal | Passing Juice |
| Culture | Internal | Passing Juice |
| Benefits | Internal | Passing Juice |
| Commercial and Medical Affairs | Internal | Passing Juice |
| Research and Development | Internal | Passing Juice |
| Technical Operations | Internal | Passing Juice |
| Corporate Functions | Internal | Passing Juice |
| Emerging Talent Programs | Internal | Passing Juice |
| Contact Us | Internal | Passing Juice |
| Learn more | Internal | Passing Juice |
| Press Releases | Internal | Passing Juice |
| Blog | Internal | Passing Juice |
| Media Asset Library | Internal | Passing Juice |
| Investors | Internal | Passing Juice |
| Learn more | Internal | Passing Juice |
| Meet our leadership team | Internal | Passing Juice |
| Explore our pipeline | Internal | Passing Juice |
| Browse current opportunities | Internal | Passing Juice |
| Read press release | Internal | Passing Juice |
| Read press release | Internal | Passing Juice |
| Read press release | Internal | Passing Juice |
| PRIVACY POLICY | Internal | Passing Juice |
| COOKIE POLICY | Internal | Passing Juice |
| SITE MAP | Internal | Passing Juice |
Keywords Cloud
release leadership read press disease rare therapy february united ultragenyx
Keywords Consistency
| Keyword | Content | Title | Keywords | Description | Headings |
|---|---|---|---|---|---|
| rare | 5 | ![]() |
![]() |
![]() |
![]() |
| disease | 5 | ![]() |
![]() |
![]() |
![]() |
| ultragenyx | 4 | ![]() |
![]() |
![]() |
![]() |
| read | 4 | ![]() |
![]() |
![]() |
![]() |
| press | 3 | ![]() |
![]() |
![]() |
![]() |
Url
Domain : ultragenyx.com
Length : 14
Favicon
Great, your website has a favicon.
Printability
We could not find a Print-Friendly CSS.
Language
Good. Your declared language is en.
Dublin Core
This page does not take advantage of Dublin Core.
Doctype
HTML 5
Encoding
Perfect. Your declared charset is UTF-8.
W3C Validity
Errors : 0
Warnings : 0
Email Privacy
Warning! At least one email address has been found in the plain text. Use free antispam protector to hide email from spammers.
Deprecated HTML
Great! We haven't found deprecated HTML tags in your HTML.
Speed Tips
![]() |
Excellent, your website doesn't use nested tables. |
![]() |
Too bad, your website is using inline styles. |
![]() |
Too bad, your website has too many CSS files (more than 4). |
![]() |
Too bad, your website has too many JS files (more than 6). |
![]() |
Perfect, your website takes advantage of gzip. |
Mobile Optimization
![]() |
Apple Icon |
![]() |
Meta Viewport Tag |
![]() |
Flash content |
XML Sitemap
Great, your website has an XML sitemap.
| https://www.ultragenyx.com/ |
Robots.txt
https://ultragenyx.com/robots.txt
Great, your website has a robots.txt file.
Analytics
Missing
We didn't detect an analytics tool installed on this website.
Web analytics let you measure visitor activity on your website. You should have at least one analytics tool installed, but It can also be good to install a second in order to cross-check the data.
Free SEO Testing Tool is a free SEO tool which provides you content analysis of the website.